bdf 9148 has been researched along with flecainide in 1 studies
| Studies (bdf 9148) | Trials (bdf 9148) | Recent Studies (post-2010) (bdf 9148) | Studies (flecainide) | Trials (flecainide) | Recent Studies (post-2010) (flecainide) |
|---|---|---|---|---|---|
| 39 | 0 | 1 | 1,881 | 229 | 490 |
| Protein | Taxonomy | bdf 9148 (IC50) | flecainide (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.8905 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barchi, RL; Davison, K; Dugrenier, N; Estep, K; Ezrin, AM; Josef, K; Kallen, RG; Krafte, DS; Silver, PJ | 1 |
1 other study(ies) available for bdf 9148 and flecainide
| Article | Year |
|---|---|
Pharmacological modulation of human cardiac Na+ channels.
Topics: Animals; Azetidines; Cardiotonic Agents; Electrophysiology; Female; Flecainide; Humans; Lidocaine; Mercaptopurine; Myocardium; Oocytes; Piperazines; Quinidine; RNA, Complementary; Sodium Channels; Tetrodotoxin; Transcription, Genetic; Xenopus laevis | 1994 |